Citigroup’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
25,467
-29,651
| -54% | -$2.48M | ﹤0.01% | 1979 |
|
|
2025
Q1 | $3.94M | Buy |
55,118
+1,285
| +2% | +$91.8K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $2.42M | Buy |
53,833
+36,785
| +216% | +$1.65M | ﹤0.01% | 1991 |
|
|
2024
Q3 | $861K | Buy |
17,048
+6,100
| +56% | +$308K | ﹤0.01% | 2656 |
|
|
2024
Q2 | $447K | Sell |
10,948
-86,806
| -89% | -$3.54M | ﹤0.01% | 2769 |
|
|
2024
Q1 | $4.18M | Buy |
97,754
+63,792
| +188% | +$2.73M | ﹤0.01% | 1344 |
|
|
2023
Q4 | $1.37M | Buy |
33,962
+33,859
| +32,873% | +$1.36M | ﹤0.01% | 1928 |
|
|
2023
Q3 | $3.04K | Buy |
+103
| New | +$3.04K | ﹤0.01% | 4110 |
|
|
2023
Q1 | – | Sell |
-100
| Closed | -$198 | – | 4915 |
|
|
2022
Q4 | $198 | Buy |
+100
| New | +$198 | ﹤0.01% | 4796 |
|
|
2022
Q3 | – | Sell |
-35
| Closed | – | – | 5360 |
|
|
2022
Q2 | $0 | Buy |
+35
| New | – | ﹤0.01% | 5688 |
|
|
2021
Q2 | – | Sell |
-263
| Closed | -$5K | – | 5616 |
|
|
2021
Q1 | $5K | Sell |
263
-479
| -65% | -$9.11K | ﹤0.01% | 5239 |
|
|
2020
Q4 | $21K | Buy |
742
+551
| +288% | +$15.6K | ﹤0.01% | 4599 |
|
|
2020
Q3 | $7K | Sell |
191
-100
| -34% | -$3.67K | ﹤0.01% | 4511 |
|
|
2020
Q2 | $10K | Buy |
+291
| New | +$10K | ﹤0.01% | 4645 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 5238 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5563 |
|
|
2015
Q3 | – | Sell |
-4
| Closed | -$1K | – | 5499 |
|
|
2015
Q2 | $1K | Sell |
4
-11
| -73% | -$2.75K | ﹤0.01% | 5362 |
|
|
2015
Q1 | $7K | Buy |
+15
| New | +$7K | ﹤0.01% | 4908 |
|